Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3048 |
|
Actual shortage: | 226 (7%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2799 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VARDENAFIL | 5MG | TABLET | Resolved | 2021-05-25 | 2021-11-01 | 139854 |
APO-VARDENAFIL | 10MG | TABLET | Resolved | 2021-05-25 | 2021-11-02 | 139857 |
APO-ALENDRONATE/VITAMIN D3 | 2800UNIT 70MG | TABLET | Resolved | 2021-05-28 | 2021-08-03 | 140066 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2021-05-28 | 2021-08-03 | 140069 |
APO-METOPROLOL | 25MG | TABLET | Resolved | 2021-05-28 | 2021-06-28 | 140072 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-05-28 | 2021-07-09 | 140075 |
APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2021-05-28 | 2021-07-30 | 140078 |
APO-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2021-06-04 | 2021-06-28 | 140414 |
APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-06-04 | 2021-06-14 | 140417 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2021-06-04 | 2021-06-22 | 140420 |
APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-04 | 2021-06-14 | 140423 |
APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2021-06-04 | 2021-06-21 | 140428 |
APO-SILDENAFIL | 25MG | TABLET | Resolved | 2021-06-04 | 2021-07-19 | 140431 |
APO-SILDENAFIL | 50MG | TABLET | Resolved | 2021-06-04 | 2021-08-23 | 140434 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2021-06-04 | 2021-08-13 | 140439 |
APO-ALENDRONATE/VITAMIN D3 | 5600UNIT 70MG | TABLET | Resolved | 2021-06-11 | 2021-08-03 | 140767 |
APO-CEFEPIME | 2G | POWDER FOR SOLUTION | Resolved | 2021-06-11 | 2021-08-06 | 140772 |
APO-DILTIAZ CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2021-06-11 | 2021-08-31 | 140775 |
APO-MYCOPHENOLIC ACID | 360MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-11 | 2021-07-26 | 140777 |
APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2021-06-11 | 2021-06-28 | 140782 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60435 |
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2018-09-15 | 60438 |
APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60443 |
APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60447 |
APO-DONEPEZIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-10-12 | 60450 |
APO-DONEPEZIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60453 |
APO-DOXY CAP 100MG | 100MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-29 | 60459 |
APO-ENALAPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-12-05 | 60462 |
APO-ENALAPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-19 | 60465 |
APO-ENALAPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60468 |
APO-ESCITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60471 |
APO-ESCITALOPRAM | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-11-16 | 60474 |
APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
APO-FUROSEMIDE | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60506 |
APO-FUROSEMIDE | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60509 |
APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |